Asia Pacific Nucleotide Market Size & Outlook, 2023-2030
Asia Pacific nucleotide market, 2018-2030 (US$M)
Asia Pacific nucleotide market highlights
- The Asia Pacific nucleotide market generated a revenue of USD 194.2 million in 2023.
- The market is expected to grow at a CAGR of 7.8% from 2024 to 2030.
- In terms of segment, deoxy nucleotides was the largest revenue generating product in 2023.
- Deoxy Nucleotides is the most lucrative product segment registering the fastest growth during the forecast period.
Asia Pacific data book summary
| Market revenue in 2023 | USD 194.2 million |
| Market revenue in 2030 | USD 328.8 million |
| Growth rate | 7.8% (CAGR from 2023 to 2030) |
| Largest segment | Deoxy nucleotides |
| Fastest growing segment | Deoxy Nucleotides |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Deoxy Nucleotides |
| Key market players worldwide | Thermo Fisher Scientific Inc, Roche, Biorigin, DSM, Promega, Agilent Technologies Inc, ABF Ingredients |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 22.8% of the global nucleotide market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 328.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Nucleotide Market Scope
Nucleotide Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific nucleotide market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to nucleotide market will help companies and investors design strategic landscapes.
Deoxy nucleotides was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Asia Pacific nucleotide market based on deoxy nucleotides covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific was the largest market for nucleotides, accounting 33.08% of the global share by volume in 2018. Rising consumer awareness regarding nutritional food habits and increasing government spending is expected to augment the market demand. Presences of the leading manufacturer in the region are expected to boost the production for nucleotides over the projected period.
In addition, increasing food & beverage additive explorations particularly in the Asia Pacific is likely to propel market growth over the forecast period. In the nucleotides using technologies for diagnostics research, the demand for Taq Man was highest, accounting approximately 3/5 of the market share in 2018.
It can replace various technologies including direct sequencing which is likely to open new avenues for industry participants. In addition, SNP by pyrosequencing was the fastest-growing technology segment. SNP technology in the region is rising with augmenting awareness and demand pertaining to increasing diagnostic research in animal breeding and pharmacogenomics sector.
Reasons to subscribe to Asia Pacific nucleotide market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific nucleotide market databook
-
Our clientele includes a mix of nucleotide market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific nucleotide market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific nucleotide market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific nucleotide market
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
